Literature DB >> 30936349

Late-onset presentation of POLG1-associated mitochondrial disease.

Bruna Meira1, Rafael Roque2, Miguel Pinto1, André Caetano1.   

Abstract

Mutations in the nuclear POLG1 gene compromise the integrity of mitochondrial DNA and show great allelic and clinical heterogeneity. Among adult POLG1-associated mitochondrial disease, the main clinical feature is chronic progressive external ophthalmoplegia. Other related clinical manifestations are sensory or cerebellar ataxia, peripheral neuropathy, myopathy or extrapyramidal symptoms. We report the case of a 72-year-old man who presented with a late onset sensory neuronopathy, chronic progressive external ophthalmoplegia, gait ataxia and parkinsonism. Genetic studies showed a compound heterozygosity of known pathogenic mutations in the POLG1 gene (variant T252I/P587 L in cis configuration in allele 1 and variant R807C in allele 2). Late life presentation highlights that mitochondrial disorders should be considered regardless of age of onset of symptoms. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  muscle disease; neuro genetics; neuromuscular disease; neuroopthalmology; parkinson’s disease

Mesh:

Substances:

Year:  2019        PMID: 30936349      PMCID: PMC6453401          DOI: 10.1136/bcr-2018-228482

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study.

Authors:  Petri Luoma; Atle Melberg; Juha O Rinne; Jyrki A Kaukonen; Nina N Nupponen; Richard M Chalmers; Anders Oldfors; Ilkka Rautakorpi; Leena Peltonen; Kari Majamaa; Hannu Somer; Anu Suomalainen
Journal:  Lancet       Date:  2004 Sep 4-10       Impact factor: 79.321

Review 2.  The clinical diagnosis of POLG disease and other mitochondrial DNA depletion disorders.

Authors:  Bruce H Cohen; Robert K Naviaux
Journal:  Methods       Date:  2010-06-15       Impact factor: 3.608

3.  Diagnostic challenges in movement disorders: Sensory Ataxia Neuropathy Dysarthria and Ophthalmoplegia (SANDO) syndrome.

Authors:  Alyson Lovan; Nikhil Balakrishnan
Journal:  BMJ Case Rep       Date:  2013-08-30

4.  SANDO: two novel mutations in POLG1 gene.

Authors:  Miguel Fernandes Gago; M J Rosas; Joana Guimarães; Mariana Ferreira; Laura Vilarinho; Lígia Castro; Stirling Carpenter
Journal:  Neuromuscul Disord       Date:  2006-08-21       Impact factor: 4.296

5.  A diagnostic flow chart for POLG-related diseases based on signs sensitivity and specificity.

Authors:  Maya Tchikviladzé; Mylène Gilleron; Thierry Maisonobe; Damien Galanaud; Pascal Laforêt; Alexandra Durr; Bruno Eymard; Fanny Mochel; Hélène Ogier; Anthony Béhin; Tanya Stojkovic; Bertrand Degos; Isabelle Gourfinkel-An; Frederic Sedel; Mathieu Anheim; Alexis Elbaz; Karine Viala; Marie Vidailhet; Alexis Brice; Claude Jardel; Anne Lombès
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-08-11       Impact factor: 10.154

Review 6.  Clinical and molecular features of POLG-related mitochondrial disease.

Authors:  Jeffrey D Stumpf; Russell P Saneto; William C Copeland
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-04-01       Impact factor: 10.005

7.  Sensory ataxic neuropathy with dysarthria and ophthalmoparesis (SANDO) in late life due to compound heterozygous POLG mutations.

Authors:  Michael D Weiss; Russell P Saneto
Journal:  Muscle Nerve       Date:  2010-06       Impact factor: 3.217

8.  Sensory ataxic neuropathy with ophthalmoparesis caused by POLG mutations.

Authors:  Margherita Milone; Nicola Brunetti-Pierri; Lin-Ya Tang; Neeraj Kumar; Michelle M Mezei; Keith Josephs; Suzanne Powell; Ericka Simpson; Lee-Jun C Wong
Journal:  Neuromuscul Disord       Date:  2008-06-27       Impact factor: 4.296

9.  Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia.

Authors:  G Van Goethem; J J Martin; B Dermaut; A Löfgren; A Wibail; D Ververken; P Tack; I Dehaene; M Van Zandijcke; M Moonen; C Ceuterick; P De Jonghe; C Van Broeckhoven
Journal:  Neuromuscul Disord       Date:  2003-02       Impact factor: 4.296

10.  SANDO syndrome in a cohort of 107 patients with CPEO and mitochondrial DNA deletions.

Authors:  Frank Hanisch; Malte Kornhuber; Charlotte L Alston; Robert W Taylor; Marcus Deschauer; Stephan Zierz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-08-20       Impact factor: 10.154

View more
  1 in total

1.  A case of drug-induced parkinsonism and tardive akathisia with e1143g polymerase γ mutation-innocent bystander or a culprit?

Authors:  Pretty Sara Idiculla; Syed Taimour Hussain; Junaid Habib Siddiqui
Journal:  J Clin Transl Res       Date:  2021-05-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.